Figure 2
From: EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
EGFR and HLA-DR expression in HNSCC. (A) Expression of EGFR in HNSCC cell lines. EGFR expression of HNSCC cell lines was examined by flow cytometry. Jurkat cells were used as negative control. (B) HLA-DR expression in HNSCC cell lines. HLA-DR expression in HNSCC cell lines was examined by flow cytometry 48 h after IFN-γ treatment as described in ‘Materials and Methods’. Jurkat was used as negative control.
